Meropenem Aptapharma (Meropenem Trihydrate)

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections across multiple organ systems.

• Complicated intra‑abdominal infections: provides rapid bactericidal activity to resolve infection and reduce mortality.
• Complicated urinary tract infections: eradicates resistant Gram‑negative and Gram‑positive pathogens in the urinary tract.
• Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant bacteria.
• Meningitis: penetrates cerebrospinal fluid to eliminate causative organisms.
• Severe sepsis and septic shock: offers rapid bacterial clearance in critically ill patients.

• Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and rapid bactericidal activity against a wide range of Gram‑negative and Gram‑positive organisms.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects

• Diarrhea: mild to moderate loose stools.
• Nausea: feeling of stomach upset.
• Rash: mild skin erythema or pruritus.
• Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects

• Seizures: particularly in patients with renal dysfunction or CNS disease.
• Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.
• Clostridioides difficile colitis: antibiotic‑associated severe diarrhea.
• Hemolytic anemia: rare immune‑mediated red cell destruction.

When using Meropenem, clinicians should consider several safety and handling precautions.

• Renal function: adjust dose in patients with impaired kidney function.
• Seizure risk: monitor patients with a history of epilepsy or CNS disorders.
• Allergies: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams.
• Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.
• Superinfection: be aware of possible overgrowth of non‑susceptible organisms, including fungi.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: concomitant use can reduce valproate levels and increase seizure risk.
• Probenecid: may decrease renal clearance of Meropenem, raising plasma concentrations.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: combined nephrotoxic potential requires renal function monitoring.
• Loop diuretics: may enhance ototoxicity when used with other nephrotoxic agents.
• Anticoagulants (e.g., warfarin): monitor INR as antibiotic therapy can alter coagulation parameters.
• Oral contraceptives: possible reduction in efficacy; advise additional contraceptive measures.